Table 3.
Number of baseline screening interpretations by each of the readers and the number of examinations recommended for a recall by reader and mode in women without breast cancer.
| FFDM | FFDM + DBT | ||||||
|---|---|---|---|---|---|---|---|
| Reader | Number of cases |
Number of Recalls |
(%) | Number of cases |
Number of Recalls |
(%) | p- value |
| Reader 1 | 4 | 1 | (25) | 4 | 0 | (0) | 1.00 |
| Reader 2 | 114 | 35 | (31) | 127 | 18 | (14) | < 0.01 |
| Reader 3 | 8 | 4 | (50) | 8 | 4 | (50) | 1.00 |
| Reader 4 | 156 | 33 | (21) | 175 | 19 | (11) | 0.01 |
| Reader 5 | 2 | 1 | (50) | 1 | 1 | (100) | 1.00 |
| Reader 6 | 51 | 18 | (35) | 63 | 21 | (33) | 0.85 |
| Reader 7 | 175 | 63 | (36) | 158 | 46 | (30) | 0.20 |
| Reader 8 | 179 | 91 | (51) | 180 | 73 | (41) | 0.06 |
| Reader 9 | 1 | 1 | (100) | 1 | 1 | (100) | 1.00 |
| Reader 10 | 51 | 17 | (33) | 53 | 15 | (28) | 0.67 |
| Reader 11 | 53 | 33 | (62) | 54 | 19 | (35) | <0.01 |
| Reader 12 | 89 | 39 | (44) | 85 | 14 | (16) | <0.01 |
| Reader 13 | 140 | 56 | (40) | 129 | 30 | (23) | <0.01 |
| Reader 14 | 51 | 20 | (39) | 36 | 13 | (38) | 0.83 |
| TOTALS | 1074 | 412 | (38) | 1074 | 274 | (26) | <0.001 |